Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Approves Its First ‘Clocked’ ANDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Application for an acne medication is first to be approved with a formal review goal under GDUFA, and comes five months early.



Related Companies